Northern Revival Acquisition (NRAC) 10-K22 Jul 242023 FY Annual reportFinancial data

Company Profile

Cover

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2023	Jul. 22, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Financial Statement Error Correction [Flag]	false
Entity Interactive Data Current	Yes
ICFR Auditor Attestation Flag	false
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Documents Incorporated by Reference [Text Block]	None
Entity Information [Line Items]
Entity Registrant Name	NORTHERN REVIVAL ACQUISITION CORPORATION
Entity Central Index Key	0001831964
Entity File Number	001-39970
Entity Tax Identification Number	98-1566600
Entity Incorporation, State or Country Code	E9
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Public Float			$ 26,094,554.92
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	4001 Kennett Pike
Entity Address, Address Line Two	Suite 302
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19807
Entity Phone Fax Numbers [Line Items]
City Area Code	(302)
Local Phone Number	338-9130
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		7,762,809
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Trading Symbol	NRACU
Security Exchange Name	NASDAQ
Class A ordinary shares, par value $0.0001 per share
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	NRAC
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	NRACW
Security Exchange Name	NASDAQ

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2023
Auditor [Table]
Auditor Name	Marcum LLP
Auditor Firm ID	688
Auditor Location	New York

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 1,465	$ 42,071
Prepaid expenses	42,917	42,517
Total current assets	44,382	84,588
Cash and Investments held in Trust Account	20,956,566	245,009,717
Total Assets	21,000,948	245,094,305
Current liabilities:
Accounts payable	146,918	19,103
Accrued expenses	1,475,712	4,679
Total current liabilities	3,542,345	83,063
Deferred legal fees	1,067,618	1,067,618
Deferred underwriting commissions		9,056,250
Forward Purchase Agreement derivative liabilities	121,584
Derivative warrant liabilities	128,550	631,430
Total liabilities	4,860,097	10,838,361
Commitments and Contingencies (Note 6)
Class A ordinary shares, $0.0001 par value; 1,910,244 and 24,150,000 shares subject to possible redemption at $10.92 per share at December 31, 2023 and $10.14 at December 31, 2022, respectively	20,856,566	244,909,717
Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Additional paid-in capital
Accumulated deficit	(4,716,319)	(10,654,377)
Total Shareholders’ Deficit	(4,715,715)	(10,653,773)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit	21,000,948	245,094,305
Class A Ordinary Shares
Shareholders’ Deficit
Common stock value	604
Class B Ordinary Shares
Shareholders’ Deficit
Common stock value		604
Related Party
Current liabilities:
Advances from related party	791,322	59,281
Promissory note – related party	$ 1,128,393

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized	5,000,000	5,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares
Ordinary shares subject to possible redemption par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption	1,910,244	24,150,000
Ordinary shares subject to possible redemption price (in Dollars per share)	$ 10.92	$ 10.14
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	500,000,000	500,000,000
Class A Ordinary Shares \| Non-Redeemable Shares
Ordinary shares, shares issued	6,037,499
Ordinary shares, shares outstanding	6,037,499
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	50,000,000	50,000,000
Ordinary shares, shares issued	1	6,037,500
Ordinary shares, shares outstanding	1	6,037,500

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2023	Dec. 31, 2022
General and administrative expenses	$ 2,570,259	$ 1,508,654
Loss from operations	(2,570,259)	(1,508,654)
Other income (expense)
Change in fair value of derivative warrant liabilities	502,880	6,399,850
Change in fair value of forward purchase agreement derivative liabilities	(121,584)
Reduction in deferred underwriter fee payable	524,538
Income from cash held in Trust Account	1,623,630	3,483,715
Total other income, net	2,529,464	9,883,565
Net (loss) income	$ (40,795)	$ 8,374,911
Redeemable Class A Ordinary Shares
Other income (expense)
Weighted average shares outstanding basic (in Shares)	3,922,676	24,150,000
Basic net income (loss) per share (in Dollars per share)	$ 0	$ 0.28
Non-redeemable Class A Ordinary Shares
Other income (expense)
Weighted average shares outstanding basic (in Shares)	4,499,177
Basic net income (loss) per share (in Dollars per share)	$ 0
Class B Ordinary Shares
Other income (expense)
Weighted average shares outstanding basic (in Shares)	1,538,323	6,037,500
Basic net income (loss) per share (in Dollars per share)	$ 0	$ 0.28

Statements of Operations (Paren

Statements of Operations (Parentheticals) - $ / shares	12 Months Ended
Statements of Operations (Parentheticals) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Redeemable Class A Ordinary Shares
Weighted average shares outstanding diluted	3,922,676	24,150,000
Diluted net (loss) income per share	$ 0	$ 0.28
Non-redeemable Class A Ordinary Shares
Weighted average shares outstanding diluted	4,499,177
Diluted net (loss) income per share	$ 0
Class B Ordinary Shares
Weighted average shares outstanding diluted	1,538,323	6,037,500
Diluted net (loss) income per share	$ 0	$ 0.28

Statements of Changes in Shareh

Statements of Changes in Shareholders’ Deficit - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021		$ 604		$ (15,619,571)	$ (15,618,967)
Balance (in Shares) at Dec. 31, 2021		6,037,500
Net income (Loss)				8,374,911	8,374,911
Remeasurement of Class A ordinary shares subject to redemption				(3,409,717)	(3,409,717)
Balance at Dec. 31, 2022		$ 604		(10,654,377)	(10,653,773)
Balance (in Shares) at Dec. 31, 2022		6,037,500
Conversion of Class B shares to Class A shares	$ 604	$ (604)
Conversion of Class B shares to Class A shares (in Shares)	6,037,499	(6,037,499)
Net income (Loss)				(40,795)	(40,795)
Reduction of underwriting fee payable				8,531,712	8,531,712
Remeasurement of Class A ordinary shares subject to redemption				(2,552,859)	(2,552,859)
Balance at Dec. 31, 2023	$ 604			$ (4,716,319)	$ (4,715,715)
Balance (in Shares) at Dec. 31, 2023	6,037,499	1

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net (loss) income	$ (40,795)	$ 8,374,911
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Income from cash held in Trust Account	(1,623,630)	(3,483,715)
Change in fair value of derivative warrant liabilities	(502,880)	(6,399,850)
Change in fair value of forward purchase agreement derivative liabilities	121,584
Reduction in deferred underwriter fee payable	(524,538)
Changes in operating assets and liabilities:
Prepaid expenses	(400)	256,970
Accounts payable	127,815	19,103
Accrued expenses	1,471,033	(45,196)
Due to related party	732,041	59,281
Deferred legal fees		462,869
Net cash used in operating activities	(239,770)	(755,627)
Cash Flows from Investing Activities:
Cash deposited in Trust Account for extensions	(929,229)
Cash withdrawn from Trust account for redemptions	226,606,010
Net cash provided by investing activities	225,676,781
Cash Flows from Financing Activities:
Proceeds from promissory note related party	1,128,393
Redemption of Class A Ordinary Shares	(226,606,010)
Offering costs paid		(70,000)
Net cash used in financing activities	(225,477,617)	(70,000)
Net change in cash	(40,606)	(825,627)
Cash - beginning of the period	42,071	867,698
Cash - end of the period	1,465	42,071
Supplemental disclosure of noncash financing activities:
Remeasurement of Class A ordinary shares subject to possible redemption	2,552,859	3,409,717
Issuance of Forward Purchase Agreement	$ 272,053

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
Description of Organization and Business Operations	Dec. 31, 2023
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Northern Revival Acquisition Corporation (the “Company,” or “NRAC”) is a blank check company incorporated as a Cayman Islands exempted company on November 4, 2020 with the name “Noble Rock Acquisition Corporation.” The Company changed its name on March 16, 2023 to Northern Revival Acquisition Corporation. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2023, the Company had not yet commenced operations. All activity through December 31, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search and closing of a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on investments held in trust from the proceeds of its Initial Public Offering. The Company’s sponsor is Northern Revival Sponsor LLC, a Cayman Island limited liability company which changed its name from Noble Rock Sponsor LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on February 1, 2021. On February 4, 2021, the Company consummated its Initial Public Offering of 24,150,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which included 3,150,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $241.5 million, and incurring offering costs of approximately $14.4 million, net of reimbursement from the underwriter. Of these offering costs, approximately $9.1 million and approximately $320,000 was for deferred underwriting commissions and deferred legal fees, respectively (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,553,334 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.8 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $241.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, or the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting fees and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity,” (“ASC 480). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to the Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. Shareholder Meeting, Extension, Redemptions and Trust Deposits On January 27, 2023, the Company held an extraordinary general meeting of its shareholders (the “Meeting”) to amend its Amended and Restated Memorandum and Articles of Association (the “Extension Amendment”) to extend the date by which the Company has to consummate an initial Business Combination from February 4, 2023 to September 4, 2023 or such earlier date as determined by the board. At the Meeting, the Company’s shareholders approved a special resolution for the Extension Proposal, (as described above). The Extension Proposal is described in detail in the Company’s definitive proxy statement filed with the SEC and dated January 6, 2023 and was approved at the Meeting. In connection with its solicitation of proxies in connection with the Extension Proposal, the Company was required to permit its public shareholders to redeem its ordinary shares. Of the 24,150,000 Class A ordinary shares outstanding with redemption rights, the holders of 21,240,830 Class A ordinary shares elected to redeem their shares at a per share redemption price of approximately $10.17. As a result, approximately $216.1 million was removed from the Trust Account to pay such holders. On March 16, 2023, the Company held an extraordinary general meeting of shareholders (the “General Meeting”) to vote on a special resolution to amend the Company’s Amended and Restated Memorandum of Association to change the name to the Company from Noble Rock Acquisition Corporation to Northern Revival Acquisition Corporation and to amend the charter to change certain provisions which restrict the Company’s Class B ordinary shares from converting to Class A ordinary shares prior to the closing of the business combination. Both proposals were approved (the “Conversion Proposal”). The submission of the Conversion Proposal entitled holders of the Company’s Class A Ordinary Shares to redeem their shares for their pro rata portion of the funds held in the Trust Account. In connection with the General Meeting, of the 2,909,170 remaining Class A ordinary shares outstanding with redemption rights, the holders of 428,699 Class A ordinary shares elected to redeem their shares at a per share redemption price of approximately $10.33 on March 28, 2023. The amount was removed from the Trust Account to pay such holders and the 428,699 shares were cancelled in April 2023. On April 5, 2023, the Sponsor elected to convert 6,037,499 Class B ordinary shares into Class A ordinary shares. As a result of such meetings, the redemptions related thereto and the Sponsor’s conversion of Class B ordinary shares into Class A ordinary shares, there were a total of 8,517,971 ordinary shares issued and outstanding, including (i) 8,517,970 Class A ordinary shares and (ii) 1 Class B ordinary share outstanding. On August 31, 2023, the Company held an annual general meeting of shareholders. At the meeting, the Company’s shareholders vote on and approved the following proposals: (1) the extension proposal — as a special resolution, to amend the company’s charter pursuant to an amendment to the charter in the form set forth in Annex A of the proxy statement, to extend the date by which the company may either (i) consummate an initial business combination, from September 4, 2023 to February 4, 2024 or such earlier date as determined by the board or (ii) cease its operations, except for the purpose of winding up if it fails to complete an initial business combination, and (iii) redeem all of the Class A ordinary shares, included as part of the units sold in the company’s Initial Public Offering that was consummated on February 4, 2021 from September 4, 2023 to February 4, 2024 or such earlier date as determined by the board; (2) the net tangible assets (“NTA”) requirement amendment proposal —as a special resolution, to amend the charter pursuant to an amendment to the charter in the form set forth in Annex B of the proxy statement, to remove the net tangible asset requirement from the charter in order to expand the methods that the company may employ so as not to become subject to the “penny stock” rules of the SEC; (3) the directors proposal — as an ordinary resolution, to reelect two (2) Class I directors to serve until the annual general meeting in 2026 and until their respective successors have been duly elected and qualified or until his or her earlier resignation, removal or death; and (4) the adjournment proposal — as an ordinary resolution, to approve the adjournment of the general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the extension proposal, the NTA requirement amendment proposal, and the directors proposal. In connection with the approval of the Extension Amendment at the Extraordinary General Meeting, holders of 570,227 of the Company’s ordinary shares exercised their right to redeem those shares for cash at an approximate price of $10.72 per share, for an aggregate of approximately $6.1 million on September 13, 2023. On January 30, 2024, the Company held an extraordinary general meeting of Shareholders and approved the 1) a special resolution, to amend the company’s Amended and Restated Memorandum and Articles of Association (the “charter”) pursuant to an amendment to the charter in the form set forth in Annex A of the accompanying proxy statement, to extend the date by which the company may either (i) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the “initial business combination”), from February 4, 2024 to August 4, 2024 (such proposal the “extension proposal”) or such earlier date as determined by the board or (ii) cease its operations, except for the purpose of winding up if it fails to complete an initial business combination, and (iii) redeem all of the Class A ordinary shares, par value $0.0001 per share, of the company (“Class A ordinary shares”), included as part of the units sold in the company’s initial public offering that was consummated on February 4, 2021 from February 4, 2024 to August 4, 2024 or such earlier date as determined by the board; and 2) an ordinary resolution, approve the adjournment of the general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the extension proposal (the “adjournment proposal”), which will be presented at the general meeting if, based on the tabulated votes, there are not sufficient votes at the time of the general meeting to approve the foregoing proposal or as otherwise deemed necessary by the Chairman of the general meeting. In connection with the shareholders’ vote at the General Meeting, 184,934 ordinary shares were tendered for redemption, leaving 7,762,810 ordinary shares, including 7,762,809 Class A ordinary shares and 1 Class B ordinary share. If the Company is unable to complete a Business Combination by August 4, 2024 and if the extension proposal to extend the date to November 4, 2024 is not approved, or such earlier date as determined by the Company’s Directors, (taking into account the extension, the “Combination Period”), the Company will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Trust Deposits In connection with the shareholders’ approval of the Extension Proposal, the Sponsor contributed to the Company as a loan (each loan being referred to herein as a “contribution”) seventh deposits of $100,000 each and five deposit of $57,307 into the Trust Account through December 31, 2023, totaling $929,229 extending the business combination date to February 4, 2024. Six deposits of $51,579 each were deposited into the Trust Account, totaling $309,474 further extending to August 4, 2024. Proposed Business Combination On March 20, 2023, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with its Sponsor, Braiin Limited, an Australian public company limited by shares (“Braiin”), and certain Braiin shareholders (the “Braiin Supporting Shareholders”) who collectively own 100% of the outstanding ordinary shares of Braiin (the “Braiin Shares”). Pursuant to the terms of the Business Combination Agreement, a business combination between NRAC and Braiin (the “Business Combination”) will be effected as a share exchange in which Braiin shareholders exchange 100% of their Braiin Shares for a pro rata portion of Class A Ordinary Shares, par value $0.0001 per share, of NRAC (the “Class A Ordinary Shares”) with an aggregate value of $190 million (the “Share Exchange”). The number of shares to be issued will be based upon a per share value of $10.00. The aggregate value is subject to adjustment up or down based upon certain indebtedness and cash on hand of Braiin as set forth in its audited financial statements. Prior to the consummation of the Business Combination, Braiin will acquire PowerTec Holdings Ltd., an Australian distributor that supplies connectivity solutions to individuals and businesses around the world. (“PowerTec”). Following the Share Exchange, Braiin will continue as a subsidiary of the Company, and the Company will change its name to “Braiin Holdings.” Reference to NRAC after giving effect to the Business Combination, as “New Braiin.” Simultaneously with the execution of the Business Combination Agreement, NRAC and Braiin entered into separate support agreements with the Braiin Supporting Shareholders and the Sponsor pursuant to which the Braiin Supporting Shareholders and the Sponsor have agreed to vote their Braiin shares and NRAC shares, respectively, in favor of the Business Combination and against any competing acquisition proposal, and not to solicit any competing acquisition proposal. In addition, the Sponsor has agreed to surrender 1,500,000 NRAC founder shares immediately prior to the closing of the Business Combination (the “Closing”) and to waive: (i) redemption rights with respect to its NRAC shares in connection with the Business Combination, and (ii) the right to have any working capital loans extended to NRAC converted into warrants. On October 1, 2023, the Company entered into an Amended and Restated Business Combination Agreement (the “Business Combination Agreement”) by and among NRAC, the Sponsor, Braiin, Braiin Holdings Ltd., a Cayman Islands exempted company (“PubCo”) and wholly owned subsidiary of NRAC, and Braiin Supporting Shareholders. Pursuant to the terms of the Amended and Restated Business Combination Agreement, the Business Combination will be effected in two steps: (i) subject to the approval and adoption of the Amended and Restated Business Combination Agreement by the shareholders of NRAC, NRAC will merge with and into PubCo and wholly owned subsidiary of NRAC with PubCo remaining as the surviving publicly traded entity (the ”Initial Business Combination”); and (ii) a share exchange in which Braiin shareholders exchange 100% of their Braiin Shares for a pro rata portion of Ordinary Shares, par value $1.00 per share, of PubCo (the “PubCo Ordinary Shares”) with an aggregate value of $572 million (the “Share Exchange”). The number of shares to be issued will be based upon a per share value of $10.00. The aggregate value is subject to adjustment up or down based upon certain indebtedness and cash on hand of Braiin as set forth in its audited financial statements. Prior to the consummation of the Business Combination, it is anticipated that Braiin will acquire PowerTec and Vega Global Technologies Pty Ltd., an Australian agricultural technology company (“Vega”). Following the Share Exchange, Braiin will continue as a subsidiary of PubCo. Reference to PubCo after giving effect to the Business Combination, as “New Braiin.” Forward Purchase Agreement In connection with the Business Combination, on March 16, 2023, the Company and Braiin entered into an OTC Equity Prepaid Forward Transaction agreement (the “Forward Purchase Agreement”) with certain funds managed by Meteora Capital, LLC, an investor in the Sponsor (the “Meteora Funds”). The Forward Purchase Agreement was entered into on March 16, 2023, prior to the signing and announcement of the Business Combination Agreement. Pursuant to the Forward Purchase Agreement, Meteora has agreed to make purchases of Class A Ordinary Shares of the Company: (a) in open-market purchases through a broker after the date of the Company’s redemption deadline in connection with the vote of the Company shareholders to approve the Business Combination from holders of Class A Ordinary Shares of the Company, including those who elect to redeem Class A Ordinary Shares and subsequently revoked their prior elections to redeem (the “Recycled Shares”) and (b) directly from the Company, newly-issued Class A Ordinary Shares of the Company (the “Additional Shares” and, together with the Recycled Shares, the “Subject Shares”). The aggregate total Subject Shares will be up to 2,900,000 (but not more than 9.9% of the Company’s Class A Ordinary Shares outstanding on a post-transaction basis) (the “Maximum Number of Shares”). Meteora has agreed to waive any redemption rights with respect to any Subject Shares in connection with the Business Combination. The Forward Purchase Agreement provides that no later than the earlier of (a) one business day after the closing of the Business Combination and (b) the date any assets from NRAC’s trust account are disbursed in connection with the Business Combination, the Combined Company will pay to Meteora, out of funds held in its Trust Account, an amount (the “Prepayment Amount”) equal to (x) the per-share redemption price (the “Initial Price”) multiplied by (y) the number of Recycled Shares on the date of such prepayment less the Prepayment Shortfall. The Prepayment Shortfall is equal to the lesser of (i) ten percent of the product of (x) the Number of NRAC Class A Ordinary Shares multiplied by (y) the Initial Price and (ii) $3,000,000. See Note 6 for additional provisions of the agreement. Underwriting Fees Waivers On August 7, 2023, Stifel, Nicolaus & Company (“Stifel”), an underwriter of the Initial Public Offering, agreed to waive its entitlement to the deferred underwriting commissions of $4,980,938 owed or payable to Stifel pursuant to the underwriting agreement for the Initial Public Offering (the “Underwriting Agreement”). As a result, the Company recognized $288,496 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $4,692,442 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6). On September 27, 2023, William Blair & Company (“Blair”), an underwriter of the Initial Public Offering, agreed to waive its entitlement to the deferred underwriting commissions of $2,037,656 owed or payable to Blair pursuant to the underwriting agreement for the Initial Public Offering (the “Underwriting Agreement”). As a result, the Company recognized $118,021 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $1,919,635 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6). On September 29, 2023, Oppenheimer & Co., Inc. (“Oppenheimer”), an underwriter of the Initial Public Offering, agreed to waive its entitlement to the deferred underwriting commissions of $2,037,656 owed or payable to Oppenheimer pursuant to the underwriting agreement for the Initial Public Offering (the “Underwriting Agreement”). As a result, the Company recognized $118,021 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $1,919,635 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6). Liquidity and going concern As of December 31, 2023, the Company had approximately $1,500 in its operating bank account and working capital deficit of approximately $3.5 million. The Company’s liquidity needs to date have been satisfied through a payment of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 5), the loan of $195,000 from the Sponsor pursuant to the Note (as defined in Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on February 5, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2023 and 2022, there were no amounts outstanding or any Working Capital Loans. Management intends to utilize Sponsor support to continue meeting its obligations. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” the Company has until August 4, 2024, or such earlier date as determined by its Directors to consummate a Business Combination. It is uncertain that the Company will be able to meet its obligations within the next 12 months or consummate a Business Combination by this time. If a Business Combination is not consummated by August 4, 2024 and if the extension proposal to extend the date to November 4, 2024 is not approved, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after. Risks and uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and the conflicts in Ukraine and Israel and their respective surrounding regions on the industry and has concluded that while it is reasonably possible that these risks and uncertainties could have a negative effect on the Company’s financial position, results of its operations and/or completing the business combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result f

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying financial statements are presented in in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2023 and 2022, the Company had no cash equivalents. Cash and Investments held in Trust Account The funds in the trust account, since the Company’s Initial Public Offering, were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act ), the Company’s has instructed Continental Stock Transfer& Trust Company, the trustee with respect to the trust account, to liquidate the U.S. government treasury obligations or money market funds held in the trust account and thereafter to hold all funds in the trust account in cash in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Business Combination, another initial business combination or our liquidation. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2023, all of the assets held in the Trust Account were held in cash. At December 31, 2022, all of the assets held in the Trust Account were held in money market funds which were invested primarily in U.S. Treasury securities. Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At December 31, 2023 and 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair value of financial instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the balance sheets. Fair value measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued warrants to purchase ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”), Embedded Derivatives (“ASC 815-15”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40, Contracts in Entity’s Own Equity (“ASC 815-40”). Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering were initially measured at fair value using a Monte Carlo simulation model. As of December 31, 2023 and 2022, the Company determined the difference between the Public Warrant and Private Warrant fair value would be de minimus and therefore measured the Private Warrants by reference to the listed trading price of the Public Warrants (See Note 10). As of December 31, 2023 and 2022, the fair value of the Public Warrants has been determined based on the observable listed trading price for such warrants. Forward Purchase Agreement Derivative Liability On March 16, 2023, the Company entered into a Forward Purchase Agreement (see Note 1). The Company accounts for the Forward Purchase Agreement as a derivative instrument in accordance with the guidance in ASC 815-40. The instrument is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the statements of operations. The ability of the Company to receive any of the proceeds of the Forward Purchase Agreement is dependent upon the financial metrics of the business combination target, among other factors, rendering the receipt of such proceeds outside the control of the Company. At December 31, 2023, the value of the forward purchase derivative liability was $121,584. Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2023 and 2022, 1,910,244 and 24,150,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount value. The changes in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net (loss) income per ordinary share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net (loss) income per ordinary share is calculated by dividing the net (loss) income by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net (loss) income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 12,603,334 shares of Class A ordinary shares in the calculation of diluted (loss) income per share, because their exercise is contingent upon future events. Remeasurement associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of ordinary shares: For the Year Ended December 31, 2023 2022 Class A Ordinary Shares subject to possible redemption Numerator: Net (loss) income allocable to Class A ordinary shares $ (16,066 ) $ 6,699,929 Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 3,922,676 24,150,000 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28 Class A Ordinary Shares, non-redeemable Numerator: Net (loss) income allocable to Class A ordinary shares (18,428 ) — Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 4,499,177 — Basic and diluted net (loss) income per share $ (0.00 ) $ — Class B Ordinary Shares Numerator: Net (loss) income allocable to Class B ordinary shares (6,301 ) 1,674,982 Denominator: Weighted Average Class B ordinary shares Basic and diluted weighted average shares outstanding 1,538,323 6,037,500 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28 Recent accounting pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its condensed consolidated financial statements and disclosures. The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
Initial Public Offering	Dec. 31, 2023
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING On February 4, 2021, the Company consummated its Initial Public Offering of 24,150,000 Units, which includes 3,150,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $241.5 million, and incurring offering costs of approximately $14.4 million, net of reimbursement from the underwriter. Of these offering costs, approximately $9.1 million and approximately $320,000 was for deferred underwriting commissions and deferred legal fees, respectively. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).

Private Placement

Private Placement	12 Months Ended
Private Placement	Dec. 31, 2023
Private Placement [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,553,334 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $6.8 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On November 11, 2020, the Initial Shareholders paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 5,750,000 Class B ordinary shares (the “Founder Shares”). On February 1, 2021, the Company declared a stock dividend with respect to the Class B ordinary shares such that 0.05 Class B ordinary shares were issued for every one Class B ordinary share, resulting in an aggregate of 6,037,500 Class B ordinary shares outstanding. The initial shareholders agreed to forfeit up to an aggregate of 787,500 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On February 4, 2021, the underwriter fully exercised its over-allotment option; thus, these 787,500 Founder Shares were no longer subject to forfeiture. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination or (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lockup. On April 5, 2023, shareholder holding one issued and outstanding Class B ordinary shares of the Company elected to convert their Class B ordinary shares into Class A ordinary shares of the Company on a one-for-one basis to meet listing requirements (see Note 9). Related Party Loans On November 11, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. Through February 4, 2021, the Company borrowed a total of $195,000 and repaid the Note in full on February 5, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2023 and 2022, the Company had no outstanding Working Capital Loans. Advances from Related Party The Sponsor, directors and officers, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee reviews on a quarterly basis all payments that were made by us to the Sponsor, directors, officers or the Company’s or any of their affiliates. For the year ended December 31, 2023, the Sponsor had advanced the Company $732,041 for working capital purposes, of which $0 was repaid during the year ended December 31, 2023. As of December 31, 2023 and 2022, the outstanding balance under the advances amounted to $791,322 and $59,281, respectively. Promissory Note – related party In connection with the shareholders’ approval of the Extension Proposal, the Sponsor contributed to the Company as a loan (each loan being referred to herein as a “contribution”) seven deposits of $100,000 each and four deposit of $57,307 into the Trust Account by December 31, 2023, totaling $929,229 extending the business combination date to February 4, 2024. The Company issued unsecured promissory notes to the Sponsor for $929,229 as extension loans as of December 31, 2023 since the funds were received in the Company operating account as of such date. The promissory notes bear no interest and all unpaid principal under the promissory notes will be due and payable in full up upon the consummation of the Business Combination. As of December 31, 2023, the Company had $1,128,393 outstanding balance under these notes. On February 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $100,000. The February 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The February 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the February 4, 2023 note to become immediately due and payable. On March 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $100,000. The March 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The March 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the March 4, 2023 note to become immediately due and payable. On April 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $100,000. The April 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The April 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the April 4, 2023 note to become immediately due and payable. On May 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $100,000. The May 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The May 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the May 4, 2023 note to become immediately due and payable. On June 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company y borrowed principal amount of $100,000. The June 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The June 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the June 4, 2023 note to become immediately due and payable. On July 4, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company y borrowed principal amount of $100,000. The July 4, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The July 4, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the July 4, 2023 note to become immediately due and payable. On August 31, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $100,000. The August 31, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The August 31, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the August 31, 2023 note to become immediately due and payable. On August 31, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $61,928. The August 31, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The August 31, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the August 31, 2023 note to become immediately due and payable. On September 1, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $57,307. The September 1, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The September 1, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the September 1, 2023 note to become immediately due and payable. On October 2, 2023, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company borrowed principal amount of $309,157. The October 2, 2023 note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. The October 2, 2023 note is subject to customary events of default which could, subject to certain conditions, cause the October 2, 2023 note to become immediately due and payable. In connection with the shareholders’ approval of the Extension Proposal, the Sponsor contributed to the Company as a loan (each loan being referred to herein as a “contribution”) seventh deposits of $100,000 each and four deposits of $57,307 into the Trust Account through December 31, 2023 totaling $929,229. As of December 31, 2023, the Company had $1,128,393 outstanding balance under unsecured promissory notes. Administrative Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor a total of $30,000 per month for office space, administrative, financial and support services. For the year ended December 31, 2023 and 2022, the Company incurred expenses under this agreement of $360,000 and $360,000, which are included in general and administrative expenses on the accompanying statements of operations, respectively. For the year ended December 31, 2023 and 2022, the Company has paid $30,000 and $0 was paid in connection with the administrative service agreement, respectively. As of December 31, 2023 and 2022, the payable was $330,000 and $0, of which is included in accrued expenses in the accompanying balance sheets, respectively.

Commitments & Contingencies

Commitments & Contingencies	12 Months Ended
Commitments & Contingencies	Dec. 31, 2023
Commitments & Contingencies [Abstract]
COMMITMENTS & CONTINGENCIES	NOTE 6. COMMITMENTS & CONTINGENCIES Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of this prospectus to purchase up to 3,150,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On February 4, 2021, the underwriter fully exercised its over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $4.8 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.375 per unit, or approximately $9.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In addition, the Company received reimbursement from the underwriters of certain expenses in connection with the Initial Public Offering in the aggregate amount of $603,750, equal to 0.25% of the offering gross proceeds. On August 7, 2023, Stifel agreed to waive its entitlement to the deferred underwriting commissions of $4,980,938 owed or payable to Stifel in accordance with the Underwriting Agreement. As a result, the Company recognized $288,496 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $4,692,442 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements. On September 27, 2023, Blair agreed to waive its entitlement to the deferred underwriting commissions of $2,037,656 owed or payable to Blair in accordance with the Underwriting Agreement. As a result, the Company recognized $118,021 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $1,919,635 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements. On September 29, 2023, Oppenheimer agreed to waive its entitlement to the deferred underwriting commissions of $2,037,656 owed or payable to Oppenheimer in accordance with the Underwriting Agreement. As a result, the Company recognized $118,021 of other income attributable to the derecognition of deferred underwriting fees allocated to offering costs and $1,919,635 was recorded to retained earnings in relation to the waiver of the deferred underwriting discount in the accompanying financial statements. As of December 31, 2023, total amounts recognized in other income amounted to $524,538 and total of $8,531,712 was recorded in Statement of changes in shareholders’ deficit. Contingent Fee Arrangement On August 4, 2022, the Company entered into an agreement with an independent third party to provide sourcing and advisory services related to completing a successful business combination. As consideration for the services to be rendered, the Company has agreed to pay them a success fee of $2,415,000, payable only upon the completion of a business combination. Any related expenses or out-of-pocket costs are borne solely by the third party. Deferred Legal Fees The Company engaged a legal counsel firm for legal advisory services, and the legal counsel agreed to defer their fees in excess of $250,000. The deferred fee will become payable in the event that the Company completes a Business Combination. As of December 31, 2023 and 2022, the Company had deferred legal fees of approximately $1.1 million in connection with such services on the accompanying balance sheets. Forward Purchase Agreement In connection with the Business Combination, on March 16, 2023, NRAC and Braiin entered into an OTC Equity Prepaid Forward Transaction agreement (the “Forward Purchase Agreement”) with certain funds managed by Meteora Capital, LLC, an investor in the Sponsor (the “Meteora Funds”). The Forward Purchase Agreement was entered into on March 16, 2023, prior to the signing and announcement of the Business Combination Agreement. Pursuant to the Forward Purchase Agreement, Meteora has agreed to make purchases of Class A Ordinary Shares of NRAC: (a) in open-market purchases through a broker after the date of NRAC’s redemption deadline in connection with the vote of NRAC shareholders to approve the Business Combination from holders of Class A Ordinary Shares of NRAC, including those who elect to redeem Class A Ordinary Shares and subsequently revoked their prior elections to redeem (the “Recycled Shares”) and (b) directly from NRAC, newly-issued Class A Ordinary Shares of NRAC (the “Additional Shares” and, together with the Recycled Shares, the “Subject Shares”). The aggregate total Subject Shares will be up to 2,900,000 (but not more than 9.9% of NRAC’s Class A Ordinary Shares outstanding on a post-transaction basis) (the “Maximum Number of Shares”). Meteora has agreed to waive any redemption rights with respect to any Subject Shares in connection with the Business Combination. The Company filed a current report on Form 8-K on March 21, 2023 with the full Business Combination Agreement and supporting agreements. The Forward Purchase Agreement provides that no later than the earlier of (a) one business day after the closing of the Business Combination and (b) the date any assets from NRAC’s trust account are disbursed in connection with the Business Combination, the Combined Company will pay to Meteora, out of funds held in its Trust Account, an amount (the “Prepayment Amount”) equal to (x) the per-share redemption price (the “Initial Price”) multiplied by (y) the number of Recycled Shares on the date of such prepayment less the Prepayment Shortfall. The Prepayment Shortfall is equal to the lesser of (i) ten percent of the product of (x) the Number of NRAC Class A Ordinary Shares multiplied by (y) the Initial Price and (ii) $3,000,000. Meteora may, at its discretion and at any time following the closing of the Business Combination, provide an Optional Early Termination notice (“OET Notice”) and pay to the Combined Company the product of the “Reset Price” and the number of NRAC’s Class A Ordinary Shares listed on the OET Notice. The Reset Price shall initially equal the Initial Price but shall be adjusted on the first scheduled trading date of each two-week period commencing on the first week following the 30 th The Forward Purchase Agreement matures on the earlier to occur of (a) three years after the closing of the Business Combination, (b) the date specified by Meteora in a written notice delivered at Meteora’s discretion if (i) the VWAP of NRAC’s Class A Ordinary Shares during 10 out of 30 consecutive trading days is at or below $5.00 per Share, or (ii) the Shares are delisted from a national securities exchange. At maturity, Meteora will be entitled to receive maturity consideration in cash or shares. The maturity consideration will equal the product of (1) (a) the Number of NRAC Class A Ordinary Shares less (b) the number of Terminated Shares, multiplied by (2) $1.50 in the event of cash or, in the event of NRAC Class A Ordinary Shares, $2.00; and $2.50, solely in the event of a registration failure. The Forward Purchase Agreement has been structured, and all activity in connection with such agreement has been undertaken, to comply with the requirements of all tender offer regulations applicable to the Business Combination, including Rule 14e-5 under the Securities Exchange Act of 1934. The Forward Purchase Agreement may be terminated by any of the parties thereto if the Business Combination Agreement is terminated pursuant to its terms prior to the closing of the Business Combination. NRAC has agreed to indemnify and hold harmless Meteora, its affiliates, assignees and other parties described therein (the “Indemnified Parties”) from and against all losses, claims, damages and liabilities under the Forward Purchase Agreement (excluding liabilities relating to the manner in which Meteora sells any shares it owns) and reimburse the Indemnified Parties for their reasonable expenses incurred in connection with such liabilities, subject to certain exceptions described therein, and has agreed to contribute to any amounts required to be paid by any Indemnified Parties if such indemnification is unavailable or insufficient to hold such party harmless. Sponsor Support Agreement and Share Surrender Simultaneously with the execution of the Business Combination Agreement, NRAC and Braiin entered into a support agreement with the Sponsor (the “Sponsor Support Agreement”) pursuant to which the Sponsor has agreed to vote its NRAC ordinary shares and its Private Placement Warrants in favor of the Business Combination and against any competing acquisition proposal, and not to solicit any competing acquisition proposal. In addition, the Sponsor has agreed to surrender 1,500,000 NRAC Class B Ordinary Shares immediately prior to the Effective Time and to waive: (i) redemption rights with respect to its NRAC shares in connection with the Business Combination, and (ii) the right to have any working capital loans extended to NRAC converted into warrants. Company Shareholder Lock-Up Agreements The consummation of the Business Combination is conditioned upon, among other things, (i) the absence of any governmental or court order, determination or injunction enjoining or prohibiting the Business Combination and related transactions, (ii) effectiveness of the Registration Statement and completion of the Shareholder Meeting, including any associated redemptions by NRAC shareholders, (iii) NRAC having at least $5,000,001 of net tangible assets (determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act) after all redemptions, (iv) approval of the Business Combination and related transactions at the Shareholder Meeting, (v) the Share Consideration being approved for listing on Nasdaq, and (vi) all necessary regulatory approvals being obtained.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	12 Months Ended
Derivative Warrant Liabilities	Dec. 31, 2023
Derivative Warrant Liabilities [Abstract]
DERIVATIVE WARRANT LIABILITIES	NOTE 7. DERIVATIVE WARRANT LIABILITIES As of December 31, 2023 and 2022, the Company had 8,050,000 Public Warrants and 4,553,334 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their warrants on a cashless basis under certain circumstances as a result of (i) the Company’s failure to have an effective registration statement by the 60 th The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the board of directors, and in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per-share redemption trigger price described under “Redemption of warrants when the price per share of Class A ordinary shares equals or exceeds $18.00” and “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $10.00 per-share redemption trigger price described under “Redemption of warrants when the price per share of Class A ordinary shares equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of (i) the Market Value and (ii) the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable by the Company, (ii) they (including Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the initial Business Combination, (iii) they may be exercised by the holders on a cashless basis and (iv) are subject to registration rights. Redemption of warrants when the price per share of Class A ordinary shares equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. Redemption of warrants when the price per share of Class A ordinary shares equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares determined by reference to an agreed table based on the redemption date and the fair market value of the Class A ordinary shares; ● if, and only if, the last reported sale price of Class A ordinary shares equals or exceeds $10.00 per share on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. The fair market value of Class A ordinary shares mentioned above shall mean the volume-weighted average price of Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	12 Months Ended
Class A Ordinary Shares Subject to Possible Redemption	Dec. 31, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION	NOTE 8. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holder of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2023 and 2022, there were 1,910,244 and 24,150,000 shares of Class A ordinary shares outstanding, all of which were subject to redemption, respectively. As of December 31, 2023 and 2022, Class A ordinary shares reflected on the balance sheets are reconciled on the following table: Class A ordinary shares subject to possible redemption at January 1, 2022 241,500,000 Plus: Increase in redemption value of Class A ordinary shares subject to redemption 3,409,717 Class A ordinary shares subject to possible redemption at December 31, 2022 244,909,717 Less: Redemption of Class A ordinary shares (226,606,010 ) Plus: Increase in redemption value of Class A ordinary shares subject to redemption 1,623,630 Extension deposits to Class A ordinary shares subject to redemption 929,229 Class A ordinary shares subject to possible redemption at December 31, 2023 $ 20,856,566

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
Shareholders' Deficit	Dec. 31, 2023
Shareholders' Deficit [Abstract]
SHAREHOLDERS’ DEFICIT	NOTE 9. SHAREHOLDERS’ DEFICIT Preference Shares – The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share. As of December 31, 2023 and December 31, 2022, there were no Class A Ordinary Shares – The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2023 and 2022, there were 1,910,244 and 24,150,000 Class A ordinary shares issued and outstanding, all subject to possible redemption and therefore classified as temporary equity on the accompanying balance sheets, respectively. See Note 8. Class B Ordinary Shares – The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. On November 11, 2020, the Company issued 5,750,000 Class B ordinary shares to the Initial Shareholders. On February 1, 2021, the Company declared a stock dividend with respect to the Class B ordinary shares such that 0.05 Class B ordinary shares were issued for each share of Class B ordinary shares, resulting in an aggregate of 6,037,500 Class B ordinary shares outstanding. All shares and associated amounts have been retroactively restated to reflect the stock dividend (see Note 5). Of the 6,037,500 Class B ordinary shares outstanding, up to 787,500 Class B ordinary shares were subject to forfeiture to the Company by the Initial Shareholders for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Initial Shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On February 4, 2021, the underwriter fully exercised its over-allotment option; thus, these 787,500 Founder Shares were no longer subject to forfeiture. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of all ordinary shares issued and outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination. On March 16, 2023, shareholders approved an amendment to the Company’s Amended and Restated Memorandum and Articles of Association permitting the conversion of Class B shares to Class A ordinary shares prior to an initial Business Combination at the option of the holder. On April 5, 2023, Sponsor elected to convert 6,037,499 Class B ordinary shares into Class A ordinary shares. Such shares do not have redemption rights. Following such meetings, the redemptions related thereto and the Sponsor’s conversion of Class B ordinary shares into Class A ordinary shares, there are a total of 8,517,971 ordinary shares issued and outstanding. At December 31, 2023, there were 7,947,743 Class A ordinary shares and 1 Class B ordinary share outstanding, respectively.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2023
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The following tables presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis, by level within the fair value hierarchy: Fair Value Measured as of Level 1 Level 2 Level 3 Total Liabilities: Derivative public warrant liabilities $ 82,110 $ — $ — $ 82,110 Derivative private placement warrant liabilities — 46,440 — 46,440 Forward purchase agreement derivative liability — — 121,584 121,584 Total derivative warrant liabilities $ 82,110 $ 46,440 $ 121,584 $ 250,134 Fair Value Measured as of Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account $ 245,009,717 $ — $ — $ 245,009,717 Liabilities: Derivative public warrant liabilities $ 403,310 $ — $ — $ 403,310 Derivative private placement warrant liabilities — 228,120 — 228,120 Total derivative warrant liabilities $ 403,310 $ 228,120 $ — $ 631,430 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. In March 2021, as the Public Warrants begun separately trading, the fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 measurement. The fair value of the Private Warrants were transferred from a Level 3 to a Level 2 during the fourth quarter of 2022 as the Company determined the difference between the Public Warrant and Private Warrant fair value would be de minimus. Level 1 assets include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants issued in connection with the Initial Public Offering were initially measured at fair value using a Monte Carlo simulation model. Subsequently, the fair value of the Public Warrants has been determined based on the observable listed trading price for such warrants. The fair value of the Private Placement Warrants has initially and subsequently been measured at fair value using a Black-Scholes Merton (BSM) model through September 30, 2022. As of December 31, 2022 through December 31, 2023, the Company determined the difference between the Public Warrant and Private Warrant fair value would be de minimus and therefore measured the Private Warrants by reference to the listed trading price of the Public Warrants. For the year ended December 31, 2023, the Company recognized a gain resulting from a decrease in the fair value of liabilities of approximately $503,000 presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. For the year ended December 31, 2022, the Company recognized a gain resulting from a decrease in the fair value of liabilities of approximately $6.4 million, presented as change in fair value of derivative warrant liabilities on the accompanying statements of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, was determined using Level 3 inputs. Inherent in a Monte Carlo simulation and BSM model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. Changes in these valuation assumptions can change the valuation significantly. The change in the fair value of the derivative warrant liabilities measured utilizing Level 3 inputs for the year ended December 31, 2022, are summarized as follows: Derivative warrant liabilities at December 31, 2021 - Level 3 $ 2,563,530 Change in fair value of derivative warrant liabilities - Level 3 (2,356,810 ) Transfer of Private Warrants to Level 2 measurement (206,720 ) Derivative warrant liabilities at December 31, 2022 - Level 3 $ — Forward Purchase Agreement Derivative Liability In order to calculate the fair value of the forward purchase agreement derivative liability, the Company utilized the following inputs: March 16, December 31, Probability of business combination 11.6 % 9.3 % Underlying ordinary share price $ 10.20 $ 10.90 Cash flow discount rate 3.72 % 4.20 % Unit purchase price $ 10.00 $ 10.00 Estimated maturity date 3/21/2026 4/26/2027 Probability of forward purchase agreement being utilized 0 % 0 % The following table presents the changes in the fair value of the forward purchase agreement derivative liability: FPA Fair value as of March 16, 2023 (initial measurement) $ 272,053 Change in fair value of the forward purchase agreement derivative liabilities (150,469 ) Change in fair value of forward purchase agreement derivative liabilities for the year ended December 31, 2023 $ 121,584 The changes in the fair value of forward purchase agreement derivative liabilities for the year ended December 31, 2023 are $150,469. There were no transfers between fair value levels during the period ended December 31, 2023 and 2022.

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred up to the date the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement, except as described below: On January 30, 2024, the Company held an extraordinary general meeting of Shareholders and approved the 1) a special resolution, to amend the company’s Amended and Restated Memorandum and Articles of Association (the “charter”) pursuant to an amendment, to extend the date by which the company may either (i) consummate a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the “initial business combination”), from February 4, 2024 to August 4, 2024 (such proposal the “extension proposal”) or such earlier date as determined by the board or (ii) cease its operations, except for the purpose of winding up if it fails to complete an initial business combination, and (iii) redeem all of the Class A ordinary shares, par value $0.0001 per share, of the company (“Class A ordinary shares”), included as part of the units sold in the company’s initial public offering that was consummated on February 4, 2021 from February 4, 2024 to August 4, 2024 or such earlier date as determined by the board; and 2) an ordinary resolution, approve the adjournment of the general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the extension proposal (the “adjournment proposal”), which will be presented at the general meeting if, based on the tabulated votes, there are not sufficient votes at the time of the general meeting to approve the foregoing proposal or as otherwise deemed necessary by the Chairman of the general meeting. In connection with the shareholders’ vote at the General Meeting, 184,934 ordinary shares were tendered for redemption, leaving 7,762,810 ordinary shares, including 7,762,809 Class A ordinary shares and 1 Class B ordinary share. On February 5, 2024, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it was no longer in compliance with the Nasdaq Listing Rules (the “Rules”). In the Notice, Nasdaq advised the Company that, pursuant to Rule IM-5101-2, a special purpose acquisition company (“SPAC”) must complete one or more business combinations within 36 months of the effectiveness of the SPAC’s initial public offering. Since the Company’s registration statement became effective on February 2, 2021, it was required to complete its initial business combination by no later than February 2, 2024. As a result, the Company’s securities were suspended from trading at the opening of business on February 14, 2024 and, on April 25, 2024, a Form 25-NSE was filed with the Securities and Exchange Commission removing the Company’s securities from listing and registration on the Nasdaq Stock Market. The Company intends to apply to be listed on Nasdaq again in connection with the closing of its business combination. Trust Deposits On March 31, 2024, the Company issued unsecured promissory notes to the Sponsor pursuant to which the Company may borrow up to an aggregate principal amount of $400,000. The payment was received into the Company’s operating account. The note is non-interest bearing, unsecured and payable upon the earlier of (i) the effective date of close of business combination, or (ii) the date of liquidation. In connection with the shareholders’ approval of the Extension Proposal, the Sponsor contributed to the Company as a loan (each loan being referred to herein as a “contribution”) seventh deposits of $100,000 each, five deposits of $57,307 and three deposits of $51,759 into the Trust Account through June 30, 2024 totaling $1,141,812.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	12 Months Ended
Pay vs Performance Disclosure - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (40,795)	$ 8,374,911

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
Accounting Policies, by Policy (Policies)	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying financial statements are presented in in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).
Emerging growth company	Emerging growth company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of estimates	Use of estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2023 and 2022, the Company had no cash equivalents.
Cash and Investments held in Trust Account	Cash and Investments held in Trust Account The funds in the trust account, since the Company’s Initial Public Offering, were held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act ), the Company’s has instructed Continental Stock Transfer& Trust Company, the trustee with respect to the trust account, to liquidate the U.S. government treasury obligations or money market funds held in the trust account and thereafter to hold all funds in the trust account in cash in an interest-bearing demand deposit account at a bank until the earlier of the consummation of the Business Combination, another initial business combination or our liquidation. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. At December 31, 2023, all of the assets held in the Trust Account were held in cash. At December 31, 2022, all of the assets held in the Trust Account were held in money market funds which were invested primarily in U.S. Treasury securities.
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At December 31, 2023 and 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair value of financial instruments	Fair value of financial instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the balance sheets.
Fair value measurements	Fair value measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative warrant liabilities	Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued warrants to purchase ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”), Embedded Derivatives (“ASC 815-15”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40, Contracts in Entity’s Own Equity (“ASC 815-40”). Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering were initially measured at fair value using a Monte Carlo simulation model. As of December 31, 2023 and 2022, the Company determined the difference between the Public Warrant and Private Warrant fair value would be de minimus and therefore measured the Private Warrants by reference to the listed trading price of the Public Warrants (See Note 10). As of December 31, 2023 and 2022, the fair value of the Public Warrants has been determined based on the observable listed trading price for such warrants.
Forward Purchase Agreement Derivative Liability	Forward Purchase Agreement Derivative Liability On March 16, 2023, the Company entered into a Forward Purchase Agreement (see Note 1). The Company accounts for the Forward Purchase Agreement as a derivative instrument in accordance with the guidance in ASC 815-40. The instrument is subject to re-measurement at each balance sheet date, with changes in fair value recognized in the statements of operations. The ability of the Company to receive any of the proceeds of the Forward Purchase Agreement is dependent upon the financial metrics of the business combination target, among other factors, rendering the receipt of such proceeds outside the control of the Company. At December 31, 2023, the value of the forward purchase derivative liability was $121,584.
Class A ordinary shares subject to possible redemption	Class A ordinary shares subject to possible redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at December 31, 2023 and 2022, 1,910,244 and 24,150,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount value. The changes in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income taxes	Income taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net (loss) income per ordinary share	Net (loss) income per ordinary share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net (loss) income per ordinary share is calculated by dividing the net (loss) income by the weighted average ordinary shares outstanding for the respective period. The calculation of diluted net (loss) income does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the private placement warrants to purchase an aggregate of 12,603,334 shares of Class A ordinary shares in the calculation of diluted (loss) income per share, because their exercise is contingent upon future events. Remeasurement associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of ordinary shares: For the Year Ended December 31, 2023 2022 Class A Ordinary Shares subject to possible redemption Numerator: Net (loss) income allocable to Class A ordinary shares $ (16,066 ) $ 6,699,929 Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 3,922,676 24,150,000 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28 Class A Ordinary Shares, non-redeemable Numerator: Net (loss) income allocable to Class A ordinary shares (18,428 ) — Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 4,499,177 — Basic and diluted net (loss) income per share $ (0.00 ) $ — Class B Ordinary Shares Numerator: Net (loss) income allocable to Class B ordinary shares (6,301 ) 1,674,982 Denominator: Weighted Average Class B ordinary shares Basic and diluted weighted average shares outstanding 1,538,323 6,037,500 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28
Recent accounting pronouncements	Recent accounting pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its condensed consolidated financial statements and disclosures. The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Schedule of Basic and Diluted Net Income (Loss) Per Share	The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of ordinary shares: For the Year Ended December 31, 2023 2022 Class A Ordinary Shares subject to possible redemption Numerator: Net (loss) income allocable to Class A ordinary shares $ (16,066 ) $ 6,699,929 Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 3,922,676 24,150,000 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28 Class A Ordinary Shares, non-redeemable Numerator: Net (loss) income allocable to Class A ordinary shares (18,428 ) — Denominator: Weighted Average Class A ordinary shares Basic and diluted weighted average shares outstanding 4,499,177 — Basic and diluted net (loss) income per share $ (0.00 ) $ — Class B Ordinary Shares Numerator: Net (loss) income allocable to Class B ordinary shares (6,301 ) 1,674,982 Denominator: Weighted Average Class B ordinary shares Basic and diluted weighted average shares outstanding 1,538,323 6,037,500 Basic and diluted net (loss) income per share $ (0.00 ) $ 0.28

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2023
Class A Ordinary Shares Subject to Possible Redemption [Abstract]
Schedule of Class A Ordinary Shares	As of December 31, 2023 and 2022, Class A ordinary shares reflected on the balance sheets are reconciled on the following table: Class A ordinary shares subject to possible redemption at January 1, 2022 241,500,000 Plus: Increase in redemption value of Class A ordinary shares subject to redemption 3,409,717 Class A ordinary shares subject to possible redemption at December 31, 2022 244,909,717 Less: Redemption of Class A ordinary shares (226,606,010 ) Plus: Increase in redemption value of Class A ordinary shares subject to redemption 1,623,630 Extension deposits to Class A ordinary shares subject to redemption 929,229 Class A ordinary shares subject to possible redemption at December 31, 2023 $ 20,856,566

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2023
Fair Value Measurements [Abstract]
Schedule of Financial Assets and Liabilities	The following tables presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis, by level within the fair value hierarchy: Fair Value Measured as of Level 1 Level 2 Level 3 Total Liabilities: Derivative public warrant liabilities $ 82,110 $ — $ — $ 82,110 Derivative private placement warrant liabilities — 46,440 — 46,440 Forward purchase agreement derivative liability — — 121,584 121,584 Total derivative warrant liabilities $ 82,110 $ 46,440 $ 121,584 $ 250,134 Fair Value Measured as of Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account $ 245,009,717 $ — $ — $ 245,009,717 Liabilities: Derivative public warrant liabilities $ 403,310 $ — $ — $ 403,310 Derivative private placement warrant liabilities — 228,120 — 228,120 Total derivative warrant liabilities $ 403,310 $ 228,120 $ — $ 631,430
Schedule of Derivative Warrant Liabilities Measured Utilizing Level 3 Inputs	The change in the fair value of the derivative warrant liabilities measured utilizing Level 3 inputs for the year ended December 31, 2022, are summarized as follows: Derivative warrant liabilities at December 31, 2021 - Level 3 $ 2,563,530 Change in fair value of derivative warrant liabilities - Level 3 (2,356,810 ) Transfer of Private Warrants to Level 2 measurement (206,720 ) Derivative warrant liabilities at December 31, 2022 - Level 3 $ —
Schedule of Fair Value of the Forward Purchase Agreement Derivative Liability	In order to calculate the fair value of the forward purchase agreement derivative liability, the Company utilized the following inputs: March 16, December 31, Probability of business combination 11.6 % 9.3 % Underlying ordinary share price $ 10.20 $ 10.90 Cash flow discount rate 3.72 % 4.20 % Unit purchase price $ 10.00 $ 10.00 Estimated maturity date 3/21/2026 4/26/2027 Probability of forward purchase agreement being utilized 0 % 0 %
Schedule of Changes in the Fair Value of the Forward Purchase Agreement	The following table presents the changes in the fair value of the forward purchase agreement derivative liability: FPA Fair value as of March 16, 2023 (initial measurement) $ 272,053 Change in fair value of the forward purchase agreement derivative liabilities (150,469 ) Change in fair value of forward purchase agreement derivative liabilities for the year ended December 31, 2023 $ 121,584

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)

1 Months Ended

12 Months Ended

Oct. 01, 2023

Sep. 29, 2023

Sep. 27, 2023

Sep. 13, 2023

Aug. 07, 2023

Apr. 05, 2023

Mar. 28, 2023

Jan. 27, 2023

Feb. 04, 2021

Apr. 30, 2023

Mar. 20, 2023

Dec. 31, 2023

Aug. 04, 2024

Dec. 31, 2022

Description of Organization and Business Operations [Line items]

Gross proceeds

$ 241,500,000

Offering costs incurred

$ 9,100,000

Private placement of the gross proceeds

$ 6,800,000

Shares price (in Dollars per share)

$ 10

Condition for future business combination use of proceeds percentage

80%

Net tangible assets

$ 5,000,001

Aggregate shares, percentage

15%

Redeem percentage

100%

Trust account to pay

$ 216,100,000

Cancelled shares (in Shares)

428,699

Ordinary shares issued and outstanding

$ 8,517,971

Ordinary shares exercised (in Shares)

570,227

Dissolution expense

$ 100,000

Redemption outstanding public shares

100%

Taxes payable

$ 100,000

Trust account price per share (in Dollars per share)

$ 10

Public share price per share (in Dollars per share)

$ 10

Deposits

$ 100,000

Trust account

$ 20,956,566

$ 51,579

$ 245,009,717

Outstanding percentage

100%

Aggregate value

$ 572,000,000

Shares (in Shares)

1,500,000

Shares to be issued (in Dollars per share)

$ 10

Lesser amount

$ 1

Purchase amount

3,000,000

Deferred underwriting commissions

$ 2,037,656

$ 4,980,938

Offering costs

1,919,635

4,692,442

Operating bank account

1,500

Working capital

3,500,000

Liquidity amount

25,000

Founder shares

$ 195,000

Private Placement [Member]

Description of Organization and Business Operations [Line items]

Units issued (in Shares)

4,553,334

Private Placement Warrant [Member]

Description of Organization and Business Operations [Line items]

Price per share (in Dollars per share)

$ 1.5

Initial Public Offering [Member]

Description of Organization and Business Operations [Line items]

Units issued (in Shares)

24,150,000

Gross proceeds

$ 241,500,000

Shares price (in Dollars per share)

$ 10

Aggregate cost

$ 603,750

Public share price per share (in Dollars per share)

$ 10

Over-Allotment Option [Member]

Description of Organization and Business Operations [Line items]

Units issued (in Shares)

3,150,000

Price per share (in Dollars per share)

$ 10

Offering costs incurred

$ 14,400,000

Deferred underwriting commissions

320,000

Common Stock [Member]

Description of Organization and Business Operations [Line items]

Ordinary shares redemption (in Shares)

7,762,810

Class A Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Shares price (in Dollars per share)

$ 18

Redemption shares outstanding (in Shares)

24,150,000

Elected to redeem share (in Shares)

21,240,830

Redemption price per share (in Dollars per share)

$ 10.17

$ 10.92

$ 10.14

Ordinary shares, shares outstanding (in Shares)

2,909,170

Redemption shares (in Shares)

428,699

Redemption price, per share (in Dollars per share)

$ 10.33

Converted shares (in Shares)

6,037,499

Ordinary shares (in Shares)

8,517,970

Ordinary shares, par value (in Dollars per share)

$ 0.0001

0.0001

Ordinary shares redemption (in Shares)

7,762,809

Outstanding percentage

9.90%

Aggregate shares (in Shares)

2,900,000

Class B Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Ordinary shares, par value (in Dollars per share)

$ 0.0001

Ordinary shares redemption (in Shares)

Extension Amendment [Member]

Description of Organization and Business Operations [Line items]

Shares price (in Dollars per share)

$ 10.72

Aggregate cost

$ 6,100,000

Trust Deposits [Member]

Description of Organization and Business Operations [Line items]

Trust account

$ 57,307

$ 309,474

Sponsor [Member]

Description of Organization and Business Operations [Line items]

Trust account

$ 929,229

General Meeting [Member]

Description of Organization and Business Operations [Line items]

Ordinary shares redemption (in Shares)

184,934

General Meeting [Member] | Class A Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Ordinary shares redemption (in Shares)

7,762,809

General Meeting [Member] | Class B Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Ordinary share outstanding (in Shares)

PubCo Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Shares price (in Dollars per share)

$ 1

Stifel, Nicolaus & Company [Member]

Description of Organization and Business Operations [Line items]

Deferred underwriting commissions

4,980,938

Other income attributable

288,496

Offering costs

$ 4,692,442

William Blair & Company [Member]

Description of Organization and Business Operations [Line items]

Deferred underwriting commissions

2,037,656

Other income attributable

118,021

Offering costs

$ 1,919,635

Oppenheimer & Co Inc [Member]

Description of Organization and Business Operations [Line items]

Deferred underwriting commissions

2,037,656

Other income attributable

118,021

Offering costs

$ 1,919,635

Initial Business Combination [Member]

Description of Organization and Business Operations [Line items]

Voting interests acquired

50%

Outstanding percentage

100%

Sponsor LLC [Member]

Description of Organization and Business Operations [Line items]

Deferred underwriting commissions

$ 320,000

NRAC [Member]

Description of Organization and Business Operations [Line items]

Shares price (in Dollars per share)

$ 10

Outstanding percentage

100%

Aggregate value

$ 190,000,000

NRAC [Member] | Class A Ordinary Shares [Member]

Description of Organization and Business Operations [Line items]

Common stock per share (in Dollars per share)

$ 0.0001

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Federal depository insurance coverage (in Dollars)	$ 250,000
Forward purchase agreement derivative liability (in Dollars)	$ 121,584
Class A Ordinary Shares [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Class A ordinary shares subject to possible redemption	1,910,244	24,150,000
Purchase aggregate	12,603,334

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Class A Ordinary Shares subject to possible redemption [Member]
Class A Ordinary Shares subject to possible redemption
Numerator: Net (loss) income allocable to ordinary shares	$ (16,066)	$ 6,699,929
Basic and diluted weighted average shares outstanding	3,922,676	24,150,000
Basic and diluted net (loss) income per share	$ 0	$ 0.28
Class A Ordinary Shares [Member]
Class A Ordinary Shares subject to possible redemption
Numerator: Net (loss) income allocable to ordinary shares	$ (18,428)
Basic and diluted weighted average shares outstanding	4,499,177
Basic and diluted net (loss) income per share	$ 0
Class B Ordinary Shares [Member]
Class A Ordinary Shares subject to possible redemption
Numerator: Net (loss) income allocable to ordinary shares	$ (6,301)	$ 1,674,982
Basic and diluted weighted average shares outstanding	1,538,323	6,037,500
Basic and diluted net (loss) income per share	$ 0	$ 0.28

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Class A Ordinary Shares subject to possible redemption [Member]
Schedule of Basic and Diluted Net Income (Loss) Per Share [Line Items]
Diluted weighted average ordinary shares outstanding	3,922,676	24,150,000
Diluted net (loss) income per share	$ 0	$ 0.28
Class A Ordinary Shares [Member]
Schedule of Basic and Diluted Net Income (Loss) Per Share [Line Items]
Diluted weighted average ordinary shares outstanding	4,499,177
Diluted net (loss) income per share	$ 0
Class B Ordinary Shares [Member]
Schedule of Basic and Diluted Net Income (Loss) Per Share [Line Items]
Diluted weighted average ordinary shares outstanding	1,538,323	6,037,500
Diluted net (loss) income per share	$ 0	$ 0.28

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)		12 Months Ended
Initial Public Offering (Details) - USD ($)	Feb. 04, 2021	Dec. 31, 2023
Initial Public Offering [Line Items]
Gross proceeds		$ 241,500,000
Offering cost	$ 9,100,000
IPO [Member]
Initial Public Offering [Line Items]
Units issued (in Shares)	24,150,000
Gross proceeds	$ 241,500,000
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Units issued (in Shares)	3,150,000
Price per unit (in Dollars per share)	$ 10
Offering cost	$ 14,400,000
Deferred underwriting commissions	$ 320,000
Class A Ordinary Shares [Member]
Initial Public Offering [Line Items]
Exercise price (in Dollars per share)		$ 11.5

Private Placement (Details)

Private Placement (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Private Placement [Line Items]
Generating gross proceeds (in Dollars) \| $	$ 6.8
Private Placement [Member]
Private Placement [Line Items]
Private placement warrants (in Shares) \| shares	4,553,334
Class A Ordinary Shares [Member]
Private Placement [Line Items]
Ordinary shares price per share	$ 11.5
Private Placement Warrant [Member]
Private Placement [Line Items]
Price per share	$ 1.5

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		12 Months Ended
Related Party Transactions (Details) - USD ($)	Nov. 11, 2020	Dec. 31, 2023	Dec. 31, 2022	Aug. 04, 2024	Feb. 04, 2024	Oct. 02, 2023	Sep. 01, 2023	Aug. 31, 2023	Jul. 04, 2023	Jun. 04, 2023	May 04, 2023	Apr. 05, 2023	Apr. 04, 2023	Mar. 04, 2023	Feb. 04, 2023	Feb. 04, 2021	Feb. 01, 2021
Related Party Transactions [Line Items]
Borrowing amount																$ 195,000
Working capital loans		$ 1,500,000
Working capital amount		732,041
Repaid amount		0
Outstanding balance amount		791,322	$ 59,281
Trust account deposit amount		20,956,566	245,009,717	$ 51,579
Unsecured promissory notes		929,229
Principal amount						$ 309,157	$ 57,307	$ 100,000	$ 100,000	$ 100,000	$ 100,000		$ 100,000	$ 100,000	$ 100,000
Trust account total amount		929,229
Office space, administrative		30,000
Incurred expenses		360,000	360,000
Administrative service agreement		30,000	0
Accrued expenses		$ 330,000	$ 0
Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Ordinary shares outstanding (in Shares)		1	6,037,500									1
Founder Shares (in Shares)		1										1
Class A Ordinary Shares [Member]
Related Party Transactions [Line Items]
Founder Shares (in Shares)		7,762,809
Exceeds per share (in Dollars per share)		$ 12
Price of per warrant (in Dollars per share)		$ 9.2
Subsequent Event [Member]
Related Party Transactions [Line Items]
Business combination					$ 929,229
Founder shares [Member]
Related Party Transactions [Line Items]
Founder Shares (in Shares)		787,500														787,500
Percentage of issued and outstanding shares		20%
Founder shares [Member] \| Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Aggregate amount	$ 25,000
Issuance of ordinary shares (in Shares)	5,750,000
Per ordinary shares (in Dollars per share)																	$ 0.05
Ordinary shares outstanding (in Shares)																	6,037,500
Sponsor [Member]
Related Party Transactions [Line Items]
Trust account deposit amount		$ 929,229
Promissory Note [Member]
Related Party Transactions [Line Items]
Amount of sponsor paid	$ 300,000
Trust account deposit amount		100,000
Principal amount								$ 61,928
Trust account deposit amount		$ 100,000
Related Party Loans [Member]
Related Party Transactions [Line Items]
Price of per warrant (in Dollars per share)		$ 1.5
Promissory Note Related Party [Member]
Related Party Transactions [Line Items]
Outstanding balance amount		$ 1,128,393
Unsecured promissory notes		1,128,393
Promissory Note Related Party [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Trust account deposit amount		57,307
Promissory Note [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Trust account deposit amount		$ 57,307

Commitments & Contingencies (De

Commitments & Contingencies (Details) - USD ($)					12 Months Ended
Commitments & Contingencies (Details) - USD ($)	Sep. 29, 2023	Sep. 27, 2023	Aug. 07, 2023	Aug. 04, 2022	Dec. 31, 2023	Dec. 31, 2022
Commitments & Contingencies [Line Items]
Underwriting discount per unit (in Dollars per share)					$ 0.2
Aggregate value					$ 9,100,000
Price per unit (in Dollars per share)					$ 0.375
Deferred underwriting commissions	$ 2,037,656	$ 2,037,656	$ 4,980,938
Deferred underwriting fees	118,021	118,021	288,496
Offering costs	$ 1,919,635	$ 1,919,635	$ 4,692,442
Other income amount					$ 524,538
Accumulated deficit reduction of underwriting fee payable					8,531,712
Success fee				$ 2,415,000
Excess of deferred legal fees					$ 250,000
Aggregate total Subject Shares (in Shares)					2,900,000
Ordinary shares outstanding percentage					9.90%
Product percentage					10%
Purchase amount					$ 3,000,000
Purchased Per share (in Dollars per share)					$ 5
Cash per share (in Dollars per share)					$ 1.5
Sponsor shares (in Shares)					1,500,000
Net intangible assets					$ 5,000,001
IPO [Member]
Commitments & Contingencies [Line Items]
Additional purchase of shares (in Shares)					3,150,000
Aggregate amount					$ 603,750
Legal Advisory Services [Member]
Commitments & Contingencies [Line Items]
Legal fee					$ 1,100,000	$ 1,100,000
Minimum [Member]
Commitments & Contingencies [Line Items]
Ordinary shares (in Shares)					2
Maximum [Member]
Commitments & Contingencies [Line Items]
Ordinary shares (in Shares)					2.5
IPO [Member]
Commitments & Contingencies [Line Items]
Aggregate value					$ 4,800,000
Gross proceeds interest rate					0.25%

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details) - $ / shares	12 Months Ended
Derivative Warrant Liabilities (Details) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Derivative Warrant Liabilities [Line Items]
Effective issue price	$ 10
Percentage of Warrant exercise price	115%
Redemption of warrants price per share	$ 10
Exceeds adjucted price per share	$ 10
Percentage of market value	180%
Redemption price per warrant	$ 0.1
Number of days for prior written notice of redemption	30 days
Reported sale of exceeds price per share	$ 10
Common stock, threshold trading days	30 days
Reference value price per share	$ 18
Private Placement [Member]
Derivative Warrant Liabilities [Line Items]
Public warrants (in Shares)	8,050,000
Private placement warrants outstanding (in Shares)		4,553,334
Percentage of total equity proceeds	60%
Class A Ordinary Shares [Member]
Derivative Warrant Liabilities [Line Items]
Redemption of warrants price per share	$ 10
Warrant exercise price per share	11.5
Effective issue price	18
Exercise price warrant	9.2
Redemption of warrants price per share	18
Exceeds adjucted price per share	10
Redemption price per warrant	$ 0.01
Number of days for prior written notice of redemption	30 days
Reported sale of exceeds price per share	$ 18
Common stock, threshold trading days	20 days
Ordinary shares price per warrant	$ 0.361
Warrant [Member]
Derivative Warrant Liabilities [Line Items]
Warrant exercise price per share	$ 11.5
Warrants expire term	5 years
Effective issue price	$ 9.2
Warrant [Member] \| Class A Ordinary Shares [Member]
Derivative Warrant Liabilities [Line Items]
Redemption of warrants price per share	$ 18

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A Ordinary Shares [Member] - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Class A Ordinary Shares Subject to Possible Redemption [Line Items]
Class A ordinary shares authorized	500,000,000	500,000,000
Class A ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock vote	one vote
Subject to Redemption [Member]
Class A Ordinary Shares Subject to Possible Redemption [Line Items]
Ordinary shares, shares outstanding	1,910,244	24,150,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption (Details) - Schedule of Class A Ordinary Shares - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Class A ordinary shares subject to possible redemption at beginning	$ 244,909,717	$ 241,500,000
Less:
Redemption of Class A ordinary shares	(226,606,010)
Extension deposits to Class A ordinary shares subject to redemption	929,229
Increase in redemption value of Class A ordinary shares subject to redemption	1,623,630	3,409,717
Class A ordinary shares subject to possible redemption at ending	$ 20,856,566	$ 244,909,717

Shareholders' Deficit (Details)

Shareholders' Deficit (Details) - $ / shares		12 Months Ended
Shareholders' Deficit (Details) - $ / shares	Apr. 05, 2023	Dec. 31, 2023	Dec. 31, 2022	Feb. 04, 2021	Feb. 01, 2021	Nov. 11, 2020
Shareholders' Deficit (Details) [Line Items]
Preference shares, authorized		5,000,000	5,000,000
Preference shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Preference shares, issued
Preference shares, outstanding
Percentage of issued and outstanding ordinary shares after initial public offering		20%
Ordinary shares issued	8,517,971
Ordinary shares outstanding	8,517,971
Class A Ordinary Shares [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares, authorized		500,000,000	500,000,000
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Common stock vote, description		Holders of the Company’s Class A ordinary shares are entitled to one vote for each share.
Temperory equity		1,910,244	24,150,000
Ordinary shares issued	6,037,499
Ordinary shares outstanding		7,947,743
Class B Ordinary Shares [Member]
Shareholders' Deficit (Details) [Line Items]
Ordinary shares, authorized		50,000,000	50,000,000
Ordinary shares, par value (in Dollars per share)		$ 0.0001	$ 0.0001
Common stock vote, description		Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders.
Common stock, issued		1	6,037,500
Stock dividend (in Dollars per share)					$ 0.05
Ordinary shares, outstanding					6,037,500
Ordinary shares, outstanding		6,037,500
Shares subject to forfeiture		787,500
Percentage of shares issued and outstanding upon completion of initial public offering		20%
Ordinary shares outstanding		1
Class B Ordinary Shares [Member] \| Common Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Common stock, issued						5,750,000
Founder Shares [Member] \| Over-Allotment Option [Member]
Shareholders' Deficit (Details) [Line Items]
Shares subject to forfeiture				787,500

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	12 Months Ended
Fair Value Measurements (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Fair Value Measurements [Line Items]
Decrease in the fair value of liabilities	$ 503,000
Fair value of derivative warrant	(502,880)	$ (6,399,850)
Derivative liabilities	(121,584)
Derivative Financial Instruments, Liabilities [Member]
Fair Value Measurements [Line Items]
Derivative liabilities	$ 150,469
Warrant [Member]
Fair Value Measurements [Line Items]
Fair value of derivative warrant		$ 6,400,000

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities - Fair Value, Recurring [Member] - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Liabilities:
Total derivative warrant liabilities	$ 250,134	$ 631,430
Assets
Investments held in Trust Account		245,009,717
Derivative public warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities	82,110	403,310
Derivative private placement warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities	46,440	228,120
Forward purchase agreement derivative liability [Member]
Liabilities:
Total derivative warrant liabilities	121,584
Level 1 [Member]
Liabilities:
Total derivative warrant liabilities	82,110	403,310
Assets
Investments held in Trust Account		245,009,717
Level 1 [Member] \| Derivative public warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities	82,110	403,310
Level 1 [Member] \| Derivative private placement warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities
Level 1 [Member] \| Forward purchase agreement derivative liability [Member]
Liabilities:
Total derivative warrant liabilities
Level 2 [Member]
Liabilities:
Total derivative warrant liabilities	46,440	228,120
Assets
Investments held in Trust Account
Level 2 [Member] \| Derivative public warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities
Level 2 [Member] \| Derivative private placement warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities	46,440	228,120
Level 2 [Member] \| Forward purchase agreement derivative liability [Member]
Liabilities:
Total derivative warrant liabilities
Level 3 [Member]
Liabilities:
Total derivative warrant liabilities	121,584
Assets
Investments held in Trust Account
Level 3 [Member] \| Derivative public warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities
Level 3 [Member] \| Derivative private placement warrant liabilities [Member]
Liabilities:
Total derivative warrant liabilities
Level 3 [Member] \| Forward purchase agreement derivative liability [Member]
Liabilities:
Total derivative warrant liabilities	$ 121,584

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of Derivative Warrant Liabilities Measured Utilizing Level 3 Inputs	12 Months Ended
	Dec. 31, 2022 USD ($)
Schedule of Derivative Warrant Liabilities Measured Utilizing Level 3 Inputs [Abstract]
Derivative warrant liabilities beginning	$ 2,563,530
Change in fair value of derivative warrant liabilities - Level 3	(2,356,810)
Transfer of Private Warrants to Level 2 measurement	(206,720)
Derivative warrant liabilities at ending

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of Fair Value of the Forward Purchase Agreement Derivative Liability - $ / shares	10 Months Ended	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2023
Schedule of Fair Value of the Forward Purchase Agreement Derivative Liability [Abstract]
Probability of business combination	11.60%	9.30%
Underlying ordinary share price (in Dollars per share)	$ 10.2	$ 10.9
Cash flow discount rate	3.72%	4.20%
Unit purchase price (in Dollars per share)	$ 10	$ 10
Estimated maturity date	Mar. 21, 2026	Apr. 26, 2027
Probability of forward purchase agreement being utilized	0%	0%

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of the Forward Purchase Agreement	10 Months Ended
	Dec. 31, 2023 USD ($)
Schedule of Changes in the Fair Value of the Forward Purchase Agreement [Abstract]
Fair value as of beginning	$ 272,053
Change in fair value of the forward purchase agreement derivative liabilities	(150,469)
Change in fair value of forward purchase agreement derivative liabilities for the year ended December 31, 2023	$ 121,584

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)		12 Months Ended
Subsequent Events (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Apr. 05, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Aggregate principal amount		$ 400,000
Class A Ordinary Shares [Member]
Subsequent Event [Line Items]
Ordinary shares, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Ordinary shares (in Shares)		7,762,809
Common Stock [Member]
Subsequent Event [Line Items]
Ordinary shares (in Shares)		184,934
Class B Ordinary Shares [Member]
Subsequent Event [Line Items]
Ordinary shares, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Ordinary shares (in Shares)		1	1
Forecast [Member]
Subsequent Event [Line Items]
Trust account	$ 1,141,812
Forecast [Member] \| Seventh Deposits [Member]
Subsequent Event [Line Items]
Deposit	100,000
Forecast [Member] \| Five Deposits [Member]
Subsequent Event [Line Items]
Deposit	57,307
Forecast [Member] \| Three Deposits [Member]
Subsequent Event [Line Items]
Deposit	$ 51,759
Extension Amendment [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Ordinary shares (in Shares)		7,762,810